TRAF6 functions as a tumor suppressor in myeloid malignancies by directly targeting MYC oncogenic activity.

[1]  D. Starczynowski,et al.  IRAK1 and IRAK4 as emerging therapeutic targets in hematologic malignancies , 2021, Current opinion in hematology.

[2]  D. Starczynowski,et al.  Innate immune pathways and inflammation in hematopoietic aging, clonal hematopoiesis, and MDS , 2021, The Journal of experimental medicine.

[3]  Francine E. Garrett-Bakelman,et al.  Chemotherapy induces senescence-like resilient cells capable of initiating AML recurrence. , 2021, Cancer discovery.

[4]  B. Gjertsen,et al.  Converging molecular evolution in acute myeloid leukaemia , 2020, medRxiv.

[5]  M. Figueroa,et al.  TNFAIP3 Plays a Role in Aging of the Hematopoietic System , 2020, Frontiers in Immunology.

[6]  A. Pourbagheri-Sigaroodi,et al.  c-Myc Inhibition Using 10058-F4 Increased the Sensitivity of Acute Promyelocytic Leukemia Cells to Arsenic Trioxide Via Blunting PI3K/NF-κB Axis. , 2020, Archives of medical research.

[7]  G. Garcia-Manero,et al.  Adaptive response to inflammation contributes to sustained myelopoiesis and confers a competitive advantage in myelodysplastic syndrome HSCs , 2020, Nature Immunology.

[8]  Kamil Slowikowski,et al.  Fast, sensitive, and accurate integration of single cell data with Harmony , 2019, Nature Methods.

[9]  M. Safa,et al.  Suppression of c‐Myc using 10058‐F4 exerts caspase‐3‐dependent apoptosis and intensifies the antileukemic effect of vincristine in pre‐B acute lymphoblastic leukemia cells , 2019, Journal of cellular biochemistry.

[10]  M. Dai,et al.  Writing and erasing MYC ubiquitination and SUMOylation , 2019, Genes & diseases.

[11]  Francisco J. Sánchez-Rivera,et al.  A Gain-of-Function p53-Mutant Oncogene Promotes Cell Fate Plasticity and Myeloid Leukemia through the Pluripotency Factor FOXH1. , 2019, Cancer discovery.

[12]  Maegan L Capitano,et al.  Toll-like receptor signaling in hematopoietic stem and progenitor cells. , 2019, Current opinion in hematology.

[13]  K. Pradhan,et al.  U2AF1 mutations induce oncogenic IRAK4 isoforms and activate innate immune pathways in myeloid malignancies , 2019, Nature Cell Biology.

[14]  A. List,et al.  The central role of inflammatory signaling in the pathogenesis of myelodysplastic syndromes. , 2019, Blood.

[15]  Kwangmin Choi,et al.  iGEAK: an interactive gene expression analysis kit for seamless workflow using the R/shiny platform , 2019, BMC Genomics.

[16]  D. Tenen,et al.  C/EBPβ is a critical mediator of IFN-α-induced exhaustion of chronic myeloid leukemia stem cells. , 2019, Blood advances.

[17]  Lai Guan Ng,et al.  Dimensionality reduction for visualizing single-cell data using UMAP , 2018, Nature Biotechnology.

[18]  A. Butte,et al.  Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage , 2018, Nature Immunology.

[19]  A. Verma,et al.  Myelodysplastic Syndrome Progression to Acute Myeloid Leukemia at the Stem Cell Level , 2018, Nature Medicine.

[20]  Claire E. Rye,et al.  COSMIC: the Catalogue Of Somatic Mutations In Cancer , 2018, Nucleic Acids Res..

[21]  D. Starczynowski,et al.  Chronic immune response dysregulation in MDS pathogenesis. , 2018, Blood.

[22]  Beth Wilmot,et al.  Functional Genomic Landscape of Acute Myeloid Leukemia , 2018, Nature.

[23]  Nancy R. Zhang,et al.  SAVER: Gene expression recovery for single-cell RNA sequencing , 2018, Nature Methods.

[24]  Paul Hoffman,et al.  Integrating single-cell transcriptomic data across different conditions, technologies, and species , 2018, Nature Biotechnology.

[25]  R. Levine,et al.  Clonal Hematopoiesis and Evolution to Hematopoietic Malignancies. , 2018, Cell stem cell.

[26]  N. Salomonis,et al.  TRAF6 Mediates Basal Activation of NF-κB Necessary for Hematopoietic Stem Cell Homeostasis , 2018, Cell reports.

[27]  B. Ebert,et al.  Agonistic targeting of TLR1/TLR2 induces p38 MAPK-dependent apoptosis and NFκB-dependent differentiation of AML cells. , 2017, Blood advances.

[28]  H. Swerdlow,et al.  Large-scale simultaneous measurement of epitopes and transcriptomes in single cells , 2017, Nature Methods.

[29]  Simon Davis,et al.  Expanding Proteome Coverage with CHarge Ordered Parallel Ion aNalysis (CHOPIN) Combined with Broad Specificity Proteolysis , 2017, Journal of proteome research.

[30]  J. Maciejewski,et al.  Epistasis between TIFAB and miR-146a: neighboring genes in del(5q) myelodysplastic syndrome , 2017, Leukemia.

[31]  M. Weirauch,et al.  Ubiquitination of the spliceosome auxiliary factor hnRNPA1 by TRAF6 links chronic innate immune signaling with hematopoietic defects and myelodysplasia , 2016, Nature Immunology.

[32]  I. Manabe,et al.  Macrophages in age-related chronic inflammatory diseases , 2016, npj Aging and Mechanisms of Disease.

[33]  J. Joly,et al.  Evaluation of off-target and on-target scoring algorithms and integration into the guide RNA selection tool CRISPOR , 2016, Genome Biology.

[34]  Gary D. Bader,et al.  Frequent mutations in acetylation and ubiquitination sites suggest novel driver mechanisms of cancer , 2016, Genome Medicine.

[35]  A. Karsan,et al.  Loss of Tifab, a del(5q) MDS gene, alters hematopoiesis through derepression of Toll-like receptor–TRAF6 signaling , 2015, The Journal of experimental medicine.

[36]  O. Winther,et al.  Tumor suppressor ASXL1 is essential for the activation of INK4B expression in response to oncogene activity and anti-proliferative signals , 2015, Cell Research.

[37]  T. Fioretos,et al.  Antibodies targeting human IL1RAP (IL1R3) show therapeutic effects in xenograft models of acute myeloid leukemia , 2015, Proceedings of the National Academy of Sciences.

[38]  Qing-Yu He,et al.  ChIPseeker: an R/Bioconductor package for ChIP peak annotation, comparison and visualization , 2015, Bioinform..

[39]  B. Ebert,et al.  Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes. , 2015, Blood.

[40]  Berthold Göttgens,et al.  Functionally Distinct Subsets of Lineage-Biased Multipotent Progenitors Control Blood Production in Normal and Regenerative Conditions. , 2015, Cell stem cell.

[41]  R. González-Prieto,et al.  c-Myc is targeted to the proteasome for degradation in a SUMOylation-dependent manner, regulated by PIAS1, SENP7 and RNF4 , 2015, Cell cycle.

[42]  A. Iwama,et al.  Myelodysplastic syndrome with extramedullary erythroid hyperplasia induced by loss of Tet2 in mice , 2015, Leukemia & lymphoma.

[43]  Wei Li,et al.  Dnmt3a loss predisposes murine hematopoietic stem cells to malignant transformation. , 2015, Blood.

[44]  P. Campbell,et al.  Combining gene mutation with gene expression data improves outcome prediction in myelodysplastic syndromes , 2015, Nature Communications.

[45]  B. Aronow,et al.  p62 is required for stem cell/progenitor retention through inhibition of IKK/NF-κB/Ccl4 signaling at the bone marrow macrophage-osteoblast niche. , 2014, Cell reports.

[46]  M. McCarthy,et al.  Age-related clonal hematopoiesis associated with adverse outcomes. , 2014, The New England journal of medicine.

[47]  S. Gabriel,et al.  Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence. , 2014, The New England journal of medicine.

[48]  Joshua F. McMichael,et al.  Age-related cancer mutations associated with clonal hematopoietic expansion , 2014, Nature Medicine.

[49]  M. Weirauch,et al.  Myeloid malignancies with chromosome 5q deletions acquire a dependency on an intrachromosomal NF-κB gene network. , 2014, Cell reports.

[50]  T. Golub,et al.  Integrated genomic analysis illustrates the central role of JAK-STAT pathway activation in myeloproliferative neoplasm pathogenesis. , 2014, Blood.

[51]  H. Aburatani,et al.  Concurrent loss of Ezh2 and Tet2 cooperates in the pathogenesis of myelodysplastic disorders , 2013, The Journal of experimental medicine.

[52]  R. Morita,et al.  TRAF6 Is Essential for Maintenance of Regulatory T Cells That Suppress Th2 Type Autoimmunity , 2013, PloS one.

[53]  David T. W. Jones,et al.  Signatures of mutational processes in human cancer , 2013, Nature.

[54]  Lesley A. Mathews,et al.  Targeting IRAK1 as a therapeutic approach for myelodysplastic syndrome. , 2013, Cancer cell.

[55]  F. Bushman,et al.  Dendritic cell expression of the signaling molecule TRAF6 is critical for gut microbiota-dependent immune tolerance. , 2013, Immunity.

[56]  A. Ferrando,et al.  The Ubiquitin Ligase FBXW7 Modulates Leukemia-Initiating Cell Activity by Regulating MYC Stability , 2013, Cell.

[57]  Benjamin J. Raphael,et al.  Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. , 2013, The New England journal of medicine.

[58]  Ryan M. O’Connell,et al.  MicroRNA-146a acts as a guardian of the quality and longevity of hematopoietic stem cells in mice , 2013, eLife.

[59]  Wei Shi,et al.  featureCounts: an efficient general purpose program for assigning sequence reads to genomic features , 2013, Bioinform..

[60]  Alex S. Arvanitakis,et al.  Selective killing of candidate AML stem cells by antibody targeting of IL1RAP. , 2013, Blood.

[61]  L. De Franceschi,et al.  Quantitative analysis of murine terminal erythroid differentiation in vivo: novel method to study normal and disordered erythropoiesis. , 2013, Blood.

[62]  A. Melnick,et al.  Methylome profiling reveals distinct alterations in phenotypic and mutational subgroups of myeloproliferative neoplasms. , 2013, Cancer research.

[63]  David N. Boone,et al.  Domain-specific c-Myc ubiquitylation controls c-Myc transcriptional and apoptotic activity , 2012, Proceedings of the National Academy of Sciences.

[64]  C. Civin,et al.  FLT3-ITD knockin impairs hematopoietic stem cell quiescence/homeostasis, leading to myeloproliferative neoplasm. , 2012, Cell stem cell.

[65]  Mithat Gonen,et al.  Recurrent Somatic TET2 Mutations in Normal Elderly Individuals With Clonal Hematopoiesis , 2012, Nature Genetics.

[66]  G. Jansen,et al.  Cytotoxic effects of bortezomib in myelodysplastic syndrome/acute myeloid leukemia depend on autophagy-mediated lysosomal degradation of TRAF6 and repression of PSMA1. , 2012, Blood.

[67]  Joshua F. McMichael,et al.  The Origin and Evolution of Mutations in Acute Myeloid Leukemia , 2012, Cell.

[68]  Guangchuang Yu,et al.  clusterProfiler: an R package for comparing biological themes among gene clusters. , 2012, Omics : a journal of integrative biology.

[69]  Steven L Salzberg,et al.  Fast gapped-read alignment with Bowtie 2 , 2012, Nature Methods.

[70]  J. Berg,et al.  Dnmt3a is essential for hematopoietic stem cell differentiation , 2011, Nature Genetics.

[71]  S. Lowe,et al.  RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia , 2011, Nature.

[72]  O. Abdel-Wahab,et al.  Tet2 loss leads to increased hematopoietic stem cell self-renewal and myeloid transformation. , 2011, Cancer cell.

[73]  P. Opolon,et al.  TET2 inactivation results in pleiotropic hematopoietic abnormalities in mouse and is a recurrent event during human lymphomagenesis. , 2011, Cancer cell.

[74]  Ryan M. O’Connell,et al.  NF-κB dysregulation in microRNA-146a–deficient mice drives the development of myeloid malignancies , 2011, Proceedings of the National Academy of Sciences.

[75]  P. Linsley,et al.  miR-146a is a significant brake on autoimmunity, myeloproliferation, and cancer in mice , 2011, The Journal of experimental medicine.

[76]  O. Abdel-Wahab,et al.  A novel tumor suppressor function for the Notch pathway in myeloid leukemia , 2011, Nature.

[77]  C. Glass,et al.  Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. , 2010, Molecular cell.

[78]  M Cazzola,et al.  Deregulated gene expression pathways in myelodysplastic syndrome hematopoietic stem cells , 2010, Leukemia.

[79]  R. Deshaies,et al.  Detection of Sequential Polyubiquitylation on a Millisecond Time-Scale , 2009, Nature.

[80]  Ken Chen,et al.  Recurring mutations found by sequencing an acute myeloid leukemia genome. , 2009, The New England journal of medicine.

[81]  Y. Kadono,et al.  TRAF6 Is Required for Generation of the B-1a B Cell Compartment as well as T Cell-Dependent and -Independent Humoral Immune Responses , 2009, PloS one.

[82]  Howard Y. Chang,et al.  Hierarchical maintenance of MLL myeloid leukemia stem cells employs a transcriptional program shared with embryonic rather than adult stem cells. , 2009, Cell stem cell.

[83]  Clifford A. Meyer,et al.  Model-based Analysis of ChIP-Seq (MACS) , 2008, Genome Biology.

[84]  L. Pham,et al.  Nuclear Tumor Necrosis Factor Receptor-associated Factor 6 in Lymphoid Cells Negatively Regulates c-Myb-mediated Transactivation through Small Ubiquitin-related Modifier-1 Modification* , 2008, Journal of Biological Chemistry.

[85]  S. Fröhling,et al.  FLT3 mutations confer enhanced proliferation and survival properties to multipotent progenitors in a murine model of chronic myelomonocytic leukemia. , 2007, Cancer cell.

[86]  M. Huang,et al.  A small-molecule c-Myc inhibitor, 10058-F4, induces cell-cycle arrest, apoptosis, and myeloid differentiation of human acute myeloid leukemia. , 2006, Experimental hematology.

[87]  L. Turka,et al.  TRAF6 is a T cell–intrinsic negative regulator required for the maintenance of immune homeostasis , 2006, Nature Medicine.

[88]  Ernest Martinez,et al.  Dual Regulation of c-Myc by p300 via Acetylation-Dependent Control of Myc Protein Turnover and Coactivation of Myc-Induced Transcription , 2005, Molecular and Cellular Biology.

[89]  J. Mesirov,et al.  From the Cover: Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005 .

[90]  B. Lüscher,et al.  Stimulation of c‐MYC transcriptional activity and acetylation by recruitment of the cofactor CBP , 2003, EMBO reports.

[91]  J. Downing,et al.  Bethesda proposals for classification of nonlymphoid hematopoietic neoplasms in mice. , 2002, Blood.

[92]  D. B. Smith,et al.  Enumeration of total coliforms and Escherichia coli from source water by the defined substrate technology , 1990, Applied and environmental microbiology.

[93]  A. Funk,et al.  Systematic evaluation of data-independent acquisition for sensitive and reproducible proteomics-a prototype design for a single injection assay. , 2016, Journal of mass spectrometry : JMS.

[94]  R. Sears,et al.  MYC degradation. , 2014, Cold Spring Harbor perspectives in medicine.

[95]  Ryan D. Morin,et al.  Identification of miR-145 and miR-146a as mediators of the 5q– syndrome phenotype , 2010, Nature Medicine.

[96]  C. Lottaz,et al.  BIOINFORMATICS APPLICATIONS NOTE , 2001 .